ADHD was originally known as a hyperkinetic reaction of childhood.
It wasn’t until the 1960s that the American Psychiatric Association formally recognised it as a neurological condition, and in the 1980s, the diagnosis became known as “attention deficit disorder with or without hyperactivity.”
Much research has been done to better understand ADHD. While researchers acknowledge that some genetic variants increase a person’s risk of ADHD, they are yet to discover a causal relationship with a particular gene or set of genes.
Furthermore, due to the complexity of the condition, there has been suggestion that a person’s environment also has a significant effect on how likely they are to develop ADHD. More research is being done to understand whether some genes require environmental triggers to switch on.
Here you'll find some of the latest local and global news and research from Google News to help us understand more about ADHD.
'Not ill at all' young people getting diagnosed with 'fashionable' ADHD, peer claims
Young people demand mental health medication despite being ‘not that ill’ – peer
Below you'll see a summary of the research pieces from New Zealand and overseas, which links to the original source, and opens in a new tab.
NZ Ministry of Health OIA: Information regarding attention deficit hyperactivity disorder (ADHD)
February 2023
Under the Official Information Act the Ministry of Health respond to a series of questions regarding the classification, diagnosis, support for ADHD and its societal impact/cost.
Shining a light on inpatient mental health services for children and adolescents in New Zealand: a view from complexity science
December 2022
Specialist inpatient mental health (IP-MH) services provide support for children and adolescents who are experiencing severe mental distress and need close observation, intensive investigation, or intervention that cannot be provided safely within a community setting.
There is limited information about such services available in the public arena and minimal research conducted in a NZ context. The aim of the research was to develop understanding of how the system is functioning today and to inform strategic policy inferences for the future.
Medication dispensing among Māori and non-Māori screened for preschool ADHD
November 2022
To investigate whether tamariki Māori screened for attention-deficit/hyperactivity disorder (ADHD) concerns in the B4 School Check (B4SC) between 2011 to 2018 are as likely to receive ADHD medication as non-Māori children.
Te Huringa: Change and Transformation. Mental Health Service and Addiction Service Monitoring Report 2022
2022
The Mental Health and Wellbeing Commission (the Commission) was set up as one of the recommendations of He Ara Oranga. One of the Commission’s functions is to monitor and report on mental health services and addiction services in New Zealand.
Survey of adults with ADHD in New Zealand
October 2021
Get insights into some of the challenges adults with ADHD have in New Zealand.
Children with additional needs
June 2021
In October 2019 an Accord was established between the primary and secondary teacher unions (NZEI Te Riu Roa and PPTA) and the Ministry of Education as part of collective bargaining. One of the agreed pieces of joint work was a scoping exercise to determine the extent of the changes in student population over time, specifically children with additional needs: We want to understand whether children are presenting with more complex health, learning and behavioural issues than in the past, whether there are greater numbers of these children and how this impacts on workload for teachers and principals starting with schools.
Adults with ADHD in Aotearoa New Zealand
2021
There is little research on the lived experiences of adults with ADHD, and none were found in Aotearoa New Zealand. The purpose of this study was to explore the similar and differing lived and ableist experiences between groups of adults who were diagnosed with ADHD in childhood, adolescence, adulthood, and those who suspect they have ADHD.
School experiences of children with ADHD in New Zealand
2021
In this Canterbury University Master's Thesis, Andrew McKegg explored the school experiences of four New Zealand primary school children diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) and the perceptions their respective parent(s) held of their child's experience of school.
New Australian Evidence-Based Clinical Guideline
October 2022
For the past two years, a large group of clinical professionals and researchers in the Australian ADHD Professionals Association (AADPA), and people with lived experience have worked extremely hard to develop the Australian evidence-based clinical practice guideline for the assessment and treatment of ADHD.
The new Australian guideline has been endorsed by the National Health and Medical Research Council.
ADHD New Zealand is encouraging the Ministry of Health to adopt the recommendations outlined in these guidelines. Hear the interview with Mark Bellgrave (Professor in Cognitive Neuroscience and President of AADPA) on Radio New Zealand.
General practitioner-centred paediatric primary care reduces risk of hospitalisation for mental disorders in children and adolescents with ADHD: findings from a retrospective cohort study
August 2022
General practitioners (GPs) play an essential role in the sustainable management of attention-deficit/hyperactivity disorder (ADHD). To our knowledge, the healthcare programme described here is the first integrated care programme for paediatric ambulatory care embedded in GP-centred-healthcare in Germany.
To compare the health-service-utilisation of patients with ADHD enrolled in a GP-centred-paediatric-primary-care-programme with usual care in terms of disease-related hospitalisation, pharmacotherapy and psychotherapy.
Dietary Interventions for ADHD: Emerging Research and Considerations
July 2022
There has been increasing interest in the role that diet and supplements play in the treatment of Attention Deficit Hyperactivity Disorder (ADHD) symptoms, from patients and researchers alike.
A dietary approach to ADHD can be complementary to a conventional pharmacological approach, giving patients and their families more options toward a personalised treatment plan. The article examines current research about diet and ADHD, review important potential mechanisms (including the role of the immune system, gut microbiome, and toxic heavy metals), and comment on promising new avenues for the treatment of ADHD.
What causes ADHD? New Israeli study may have found out
December 2021
CDH2 is a gene that encodes N-cadherin, which is responsible for helping in brain synapse activity and formation.
A mutation in CDH2, however, alters this activity. This, in turn, impacts molecular pathways and dopamine levels in two specific brain structures: the ventral midbrain and the prefrontal cortex, both of which are involved in ADHD.
The implications of this finding could help pave the way for further understanding how ADHD works, and how it can be treated and managed.
One in Six College Freshmen Has ADHD — Most with Comorbidities
November 2021
From a World Health Organization survey of 16,000 college students across nine countries, researchers found that roughly 16 percent have ADHD. In addition, 58 percent of students with ADHD have at least one comorbid disorder; 30 percent have two or more comorbid conditions.
Adults with ADHD Face Elevated Risk for 34 Physical Health Conditions
August 2021
A study of roughly 4.8 million patient records found that adults with ADHD exhibit elevated risk for 34 of 35 physical conditions studied, including nervous system, respiratory, musculoskeletal, metabolic, circulatory, gastrointestinal, genitourinary, and skin conditions.
Only 1 in 10 children with ADHD will outgrow symptoms
August 2021
Findings from the Multimodal Treatment Study of ADHD, which followed 558 children, show that only 9.1 percent of subjects “recovered” from ADHD.
Efficacy of Non-pharmacological Treatments on Emotional Symptoms of Children and Adults with Attention-Deficit/Hyperactivity Disorder
March 2021
Researchers concluded that “while adults might benefit from more complex forms such as Cognitive Behaviour Therapy (CBT), children with ADHD will benefit from more intuitive non-pharmacological interventions involving social relationships and interaction skills.”
DESR a Core Component of ADHD in Children, Leading to Sleep Difficulties
February 2021
Deficient emotional self-regulation (DESR) ia defined as “emotional impulsiveness, difficulties inhibiting inappropriate response, problems refocusing attention and disorganization of coordinated action in response to emotional activation, resulting in extreme responses that would be considered inappropriate for the developmental age of the person”.It is more common and aggravated among children with untreated ADHD and is linked to greater sleep problems.
The material on our website is provided for educational purposes only. Your use of our website is governed by our Privacy Policy and Disclaimer. We are a not-for-profit organisation that can provide you wtih ongoing support in your ADHD journey. However, we do not provide medical advice, assessment, diagnosis, or treatment. Your GP can recommend a suitable healthcare professional to you.
Content on ADHD.org.nz is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License.